ArticleVox sanguinis2026
Molecular characterization of D variants in Brazilian blood donors and their association with RhCE and Duffy phenotypes.
Article in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
objectivesSerological classification of RhD-negative and weak D is often insufficient in admixed populations, where diverse RHD variants have clinical implications. In Brazil's highly admixed population, RhD interpretation and donor-recipient matching are particularly challenging. We used Duffy phenotyping to support ancestry inference and contextualize Rh variants. Understanding RHD alleles and their associations with RhCE and Duffy is essential for transfusion safety. Here, we characterize RHD variants in Brazilian donors and relate them to RhCE and Duffy phenotypes across regions. MATERIALS AND
methodsWe analysed 321 blood donor samples with either weak D expression (n = 295) or a D-negative phenotype with C and/or E antigen positivity (n = 26). RhD, RhCE and Duffy phenotyping was performed, followed by RHD, RHCE and FY genotyping using multiplex polymerase chain reaction with sequence-specific primers (PCR, PCR-SSP) and real-time PCR. Samples unresolved by targeted assays underwent sequencing.
resultsAmong weak D donors, 88% carried known RHD variants, with weak D types 1, 2 and 3 accounting for 67% of cases. Partial D alleles such as DAR, DAU4 and weak partial 11 were identified, particularly among donors with Fy(a-b-) and Fy(a+b-) phenotypes, often associated with RHCE*733G. In the D-negative group, 50% of samples harboured non-functional or hybrid RHD alleles, including RHD*03N.01/RHD*08N.01 and RHD*08N.01/RHD*01N.01, linked to the r's haplotype and RHCE*ceS allele.
conclusionThis study reveals the wide spectrum of RHD variants in an admixed population and underscores the importance of integrating molecular genotyping and phenotype associations to improve transfusion safety and guide Rh immunoprophylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.